Lethal metabolism of Candida albicans respiratory mutants

D Lucas Kane1, Brendan Burke2, Monica Diaz2

  • 1Department of Chemistry and Medicinal Chemistry Shared Resource, Georgetown University, Washington, DC, United States of America.

Plos One
|April 5, 2024
PubMed

Insights

New research reveals a lethal interaction between acetal and purines in Candida albicans metabolism. This finding offers potential new antifungal drug targets to combat rising antifungal resistance.

Area of Science:

  • Mycology
  • Biochemistry
  • Medical Microbiology

Background:

  • Fungal infections pose significant threats to agriculture, animal, and human health.
  • Increasing antifungal resistance necessitates novel drug targets and therapeutic strategies.
  • Understanding toxic metabolic byproducts can inform antifungal development.

Purpose of the Study:

  • To investigate media-conditional lethality in respiratory mutants of Candida albicans.
  • To identify the toxic factors produced by these mutants.
  • To explore novel antifungal targets based on metabolic vulnerabilities.

Main Methods:

  • Culturing Candida albicans mutants defective in NADH:ubiquinone oxidoreductase (Complex I).
  • Assessing cell viability in different media (synthetic complete vs. YPD) and conditioned media.
  • Utilizing GC-mass spectrometry for chemical analysis of toxic components.
  • Conducting fractionation experiments to identify synergistic factors.

Main Results:

  • Complex I mutants exhibit normal growth in synthetic complete medium but undergo rapid cell death in YPD medium.
  • Cell death in YPD medium is dependent on BactoPeptone and yeast extract concentration.
  • Mutant-conditioned YPD medium is toxic to wild-type cells, indicating the production of a toxic milieu.
  • A lethal synergistic interaction was identified between acetal (a volatile compound) and purines (from BactoPeptone).

Conclusions:

  • Candida albicans Complex I mutants generate a toxic metabolic byproduct in specific media conditions.
  • The synergistic toxicity of acetal and purines represents a previously unrecognized metabolic pathway.
  • This pathway presents a potential new target for antifungal drug development to combat resistant fungal infections.